Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps the Government is taking to work with (a) the life sciences industry and (b) experts in radioligand therapy in relation to the development of secondary legislation to enact the provisions of the Medicines and Medical Devices Bill.

The Department has held a number of engagement events with over 150 representatives from the life sciences industry on the Medicines and Medical Devices Bill and we will continue to work collaboratively with the sector when making secondary legislation. The powers in the Medicines and Medical Devices Bill are subject to a duty to consult and therefore before making any regulations, the Department will consult with those considered appropriate. This will include the life sciences industry and expert stakeholders if they were to be affected by the proposed change.